Month: December 2017
Immunity to CRISPR Cas9 and Cas12a Therapeutics

Immunity to CRISPR Cas9 and Cas12a Therapeutics

Genome-editing therapeutics introduce foreign nucleic acids and proteins into the circulation and cells, which can activate the innate, cellular, and humoral immunity in human patients. The key obstacle in translating CRISPR therapeutics to the clinic is hence to identify, diminish, and monitor these immunological risks before adverse immune reactions.

Confererence Report: TEDx Berlin

Confererence Report: TEDx Berlin

This year’s edition of TEDx Berlin, entitled “FOCUS”, was held on September 3rd and encompassed three sessions with invited speakers in different topics covering Digital Life and its challenges. Image copyright TEDxBerlin 2017.